SCHEMBL23666705

SCHEMBL23666705

CCCC(CCC)c1ccc(C(F)(F)F)c(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
AKR1C3 P42330 12/20 0.35
AKR1C2 P52895 12/20 0.35
AKR1B10 O60218 3/20 0.34
AKR1C4 P17516 3/20 0.34
AKR1C1 Q04828 3/20 0.34
DAO P14920 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
RPS6KB1 P23443 1/20 0.32
AKT1 P31749 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
GRIA4 P48058 1/20 0.31
ADRB2 P07550 1/20 0.31
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19003574 0.93 AKR1C3 (0.36) ESR1ESR2AKR1C3AKR1C2AKR1B10
SCHEMBL19820209 0.84 AKR1C3 (0.42) AKR1C3AKR1C2
SCHEMBL23666664 0.84 AKR1C3 (0.34) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL18948448 0.82 NR1I2 (0.46) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL20414528 0.80 AR (0.37) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL21125230 0.78 AKR1C3 (0.43) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL21125000 0.78 AKR1C3 (0.38) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL28411135 0.77 AKR1C3 (0.42) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL20178592 0.76 CFTR (0.43) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1
SCHEMBL19003629 0.76 CTSS (0.39) AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210221781-A1 FATTY ACID ANALOGUES AND METHODS OF USE LIN BIOSCIENCE INC. (TW) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221781-A1 FATTY ACID ANALOGUES AND METHODS OF USE ELOVL1, FADS1, ALOX5 ESR1 2726/4885ESR2 1639/4885AKR1C3 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.